Zhongming Zhang: Clinical Trials

1 trial sponsored by Zhongming Zhang, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Zhongming Zhang: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major
Basiliximab,, Tacrolimus, Methotrexate - Beta-Thalassemia Major, Graft-versus-host Disease (GVHD)
Phase 4CompletedZhongming Zhang2052015-04-012025-06-18

Conditions studied

Graft vs Host Disease (1)  ·  beta-Thalassemia (1)

Interventions

Basiliximab (1)  ·  Methotrexate (1)  ·  Mycophenolic Acid (1)  ·  Tacrolimus (1)

Countries

China (1)

Results publications

PMID 16273116, PMID 16737942